[1]
2025. Beyond Glucose: Empagliflozin’s Impact on Fatty Liver in Patients with Type 2 Diabetes; A True Game Changer. Indus Journal of Bioscience Research. 3, 2 (Feb. 2025), 193–198. DOI:https://doi.org/10.70749/ijbr.v3i2.663.